Primary Record
Sotagliflozin
- In stock
- 1,611 g
- Purity
- 99.8 %
- CAS
- 1018899-04-1
Compound Identifiers & Properties
- CAS
- 1018899-04-1
- PubChem CID
- 24831714
- SMILES
- CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)SC)O)O)O)Cl
- Canonical SMILES
- CCOc1ccc(Cc2cc([C@@H]3O[C@H](SC)[C@@H](O)[C@H](O)[C@H]3O)ccc2Cl)cc1
Names & Synonyms
- Sotagliflozin
- LX-4211
- 1018899-04-1
- sotagliflozina
- sotagliflozine
- Zynquista
- sotagliflozinum
- LX4211
- INPEFA
- Inpefa (TN)
- C21H25ClO5S
- Tube103
- RefChem:57075
- Sotagliflozin [USAN:INN]
- 6B4ZBS263Y
- UNII-6B4ZBS263Y
- Sar439954
- MFCD22493506
- SOTAGLIFLOZIN [MI]
- D0U7IL
- Sotagliflozin (LX4211)
- SOTAGLIFLOZIN [INN]
- Sar-439954
- Sotagliflozin (USAN/INN)
- SOTAGLIFLOZIN [USAN]
- Sotagliflozin (LX-4211)
- LP-802034
- DTXSID20144314
- Sotagliflozin (LX-4211)?
- SOTAGLIFLOZIN [WHO-DD]
- GTPL8312
- orb1304078
- SCHEMBL1038287
- CHEMBL3039507
- DTXCID7066805
- SCHEMBL29433934
- LX 4211
- A10BK06
- CHEBI:229226
- GLXC-90534
- AMY12393
- EX-A1167
- LP 802034
- 3792AH
- BDBM50235017
- EBC-27052
- MSK177667
- s8103
- ZINC95641922
- AKOS025290846
- (2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol
- ACN-037454
- CCG-268940
- CM11080
- CS-1069
- DB12713
- 4CA-0766
- AC-29890
- AS-35202
- BC600522
- BL161424
- HY-15516
- SC-94335
- SY235565
- AB0165653
- NS00073087
- J3.750.394K
- A12680
- D10669
- W-5944
- EN300-7399851
- A852129
- F979680
- (2S,3R,4R,5S,6R)-2-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-6-methylsulfanyloxane-3,4,5-triol
- beta-L-Xylopyranoside, methyl 5-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-1-thio-, (5S)-
- BRD-K05850076-001-01-5
- Q27088840
- B0084-463492
- beta-l-Xylopyranoside, methyl 5-C-(4-chloro-3-((4-ethoxyphenyl)methyl)phenyl)-1-thio-, (5S)-
- (2S,3R,4R,5S,6R)-2-{4-CHLORO-3-[(4-ETHOXYPHENYL)METHYL]PHENYL}-6-(METHYLSULFANYL)OXANE-3,4,5-TRIOL
- (2S,3R,4R,5S,6R)-2-[4-chloranyl-3-[(4-ethoxyphenyl)methyl]phenyl]-6-methylsulfanyl-oxane-3,4,5-triol
- (2S,3R,4R,5S,6R)-2-[4-Chloro-3-(4-ethoxybenzyl)phenyl]-6-(methylsulfanyl)tetrahydro-2H-pyran-3,4,5-triol
- methyl (5S)-5-[4-chloro-3-(4-ethoxybenzyl)phenyl]-1-thio-beta-L-xylopyranoside
- Methyl (5S)-5-{4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl}-1-thio-beta-L-xylopyranoside
- (2S,3R,4R,5S,6R)-2-(4-chloro-3-((4-ethoxyphenyl)methyl)phenyl)-6-(methylsulfanyl)oxane-3,4,5-triol
- (2S,3R,4R,5S,6R)-2-(4-chloro-3-((4-ethoxyphenyl)methyl)phenyl)-6-methylsulfanyloxane-3,4,5-triol
- (2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)- 6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol
- (2S,3R,4R,5S,6R)-2-[4-chloro-3-(4-ethoxybenzyl)phenyl]-6-(methylsulfanyl)tetrahydro-2-H-pyran-3,4,5-triol
- (2S,3R,4R,5S,6R)-2-[4-Chloro-3-(4-ethoxybenzyl)phenyl]-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol
- (2S,3R,4R,5S,6R)-2-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-6-methylsulfanyl-tetrahydropyran-3,4,5-triol
- .BETA.-L-XYLOPYRANOSIDE, METHYL 5-C-(4-CHLORO-3-((4-ETHOXYPHENYL)METHYL)PHENYL)-1-THIO-, (5S)-
- |A-L-Xylopyranoside, methyl 5-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-1-thio-, (5S)-
- b-L-Xylopyranoside, methyl 5-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-1-thio-, (5S)-;b-L-Xylopyranoside, methyl 5-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-1-thio-, (5S)-
- Lfl
- LX-4211|||LP-802034|||(2S,3R,4R,5S,6R)-2-[4-Chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-6-methylsulfanyloxane-3,4,5-triol
- METHYL (5S)-5-C-(4-CHLORO-3-((4-ETHOXYPHENYL)METHYL)PHENYL)-1-THIO-.BETA.-L-XYLOPYRANOSIDE
- Sotagliflozin; ss-L-Xylopyranoside, methyl 5-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-1-thio-, (5S)-; (5S)-Methyl 5-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-1-thio-ss-L-xylopyranoside; LP 802034; LX 4211; Sotagliflozin; Zynquista
- Zynquista; (2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol